Have a personal or library account? Click to login
A comparison of the monocyte monolayer assay with 51chromium red cell recovery for determining the clinical significance of red cell alloantibodies Cover

A comparison of the monocyte monolayer assay with 51chromium red cell recovery for determining the clinical significance of red cell alloantibodies

By: R.J. Davey,  S.S Esty,  J.F. Chin and  D. Mallory  
Paid access
|Nov 2020

References

  1. Abramson N, Gelfand EW, Jandl JH, Rosen FS. The interaction between human monocytes and red cells: specificity for IgG subclass and IgG fragments. J Exp Med 1970;132:1208–15.10.1084/jem.132.6.120721805005511570
  2. Huber H, Douglas SD, Nusbacher J, Kochwa S, Rosenfield RE. IgG subclass specificity of human monocyte receptor sites. Nature 1971;229:419–20.10.1038/229419a04926996
  3. Mason DY. Monocyte ingestion of IgG-coated erythrocytes from haemolysing and non-haemolysing subjects. Acta Haematol 1976;55:1–9.10.1159/000207987816133
  4. Schanfield MS. Two methods of studying erythrocyte survival: differential agglutination tests and effector cell assays. In: Butch S, ed. Clinically significant and insignificant antibodies. Washington: American Association of Blood Banks, 1979:57–70.
  5. Hunt JS, Beck ML, Hardman JT, Tegtmeier GE, Bayer WL. Characterization of human erythrocyte alloantibodies by IgG subclass and monocyte interaction. Am J Clin Pathol 1980;74:259–64.10.1093/ajcp/74.3.2597416078
  6. Nance S, Garratty G. Correlations between an in vitro monocyte monolayer assay and autoimmune hemolytic anemia (AIHA) (abstract). Transfusion 1982;22:410.
  7. Schanfield MS, Schoeppner SL, Stevens JO. New approaches to detecting clinically significant antibodies in the laboratory. In: Sandler JS, ed. Immunobiology of the erythrocyte. New York: AlanR. Liss, Inc., 1980:305–23.
  8. Branch DR, Gallagher MT, Mison AP, Sy Siok Hian AL, Petz LD. In vitro determination of red cell alloantibody significance using an assay of monocyte-macrophage interaction with sensitized erythrocytes. Br J Haematol 1984;56:19–29.10.1111/j.1365-2141.1984.tb01268.x6704325
  9. Douglas R, Rowthrone NV, Schneider JV. Some quantitative aspects of the human monocyte erythrophagocytosis and rosette assays. Transfusion 1985;25:535–9.10.1046/j.1537-2995.1985.25686071425.x3934803
  10. Schanfield MS, Stevens JO, Bauman D. The detection of clinically significant erythrocyte alloantibodies using a human mononuclear phagocyte assay. Transfusion 1981;21:571–6.10.1046/j.1537-2995.1981.21582040822.x6794195
  11. Hunt JS, Beck ML, Tegtmeier GE, Bayer WL. Factors influencing monocyte recognition of human erythrocyte autoantibodies in vitro. Transfusion 1982;22:355–8.10.1046/j.1537-2995.1982.22583017456.x6812246
  12. Wren MR, Issitt PD. The monocyte monolayer assay and in vivo antibody activity (abstract). Transfusion 1986;26:548.
  13. Nance SJ, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:449–52.10.1046/j.1537-2995.1987.27688071692.x3686653
  14. Gallagher MT, Branch DR, Mison Λ, Petz LD. Evaluation of reticuloendothelial function in autoimmune hemolytic anemia using an in vitro assay of monocyte-macrophage interaction with sensitized erythrocytes. Exp Haematol 1983;11:82–9.
  15. Baldwin ML, Ness PM, Barrasso C, Kickler TS, Drew H, Tsan MF, Shirey RS. In vivo studies of the long-term 51Cr red cell survival of serologically incompatible red cell units. Transfusion 1985;25:34–8.10.1046/j.1537-2995.1985.25185116499.x3969699
  16. Mollison PL. Blood transfusion in clinical medicine. 7th ed. Oxford: Blackwell Scientific Publications, 1983:781–3.
  17. International Committee for Standardization in Haemotology. Recommended methods for radioisotope red-cell survival studies. Br J Haematol 1980;45:659–66.10.1111/j.1365-2141.1980.tb07189.x7426443
  18. Polley MJ, Mollison PL. The role of complement in the detection of blood group antibodies: special reference to the antiglobulin test. Transfusion 1961;1:9–22.10.1111/j.1537-2995.1961.tb00006.x13736868
  19. Davey RJ, Gustafson M, Holland PV. Accelerated immune red cell destruction in the absence of serologically detectable antibodies. Transfusion 1980;20:348–53.10.1046/j.1537-2995.1980.20380214905.x6770508
  20. Walford RI, Taylor P. An in vivo crossmatching procedure for selected problem cases in blood banking. Transfusion 1964;4: 372-4.10.1111/j.1537-2995.1964.tb02891.x14205858
  21. Esty SS, Wahl T, Zawisza J, Mallory D, Davey RJ. Stimulation of antibody following 51chromium survival studies. Immunohematology 1987;3:6–8.10.21307/immunohematology-2019-1119
  22. Kickler TS, Smith B, Bell W, Drew H, Baldwin M, Ness PM. Estimation of transfused red cell survival using an enzyme- linked antiglobulin test. Transfusion 1985;25:401–5.10.1046/j.1537-2995.1985.25586020109.x4049483
  23. Crabill HE, Davey RJ, AuBuchon J, Anderson G, Cupp J. Application of flow cytometry in the identification of minor red cell populations (abstract). Transfusion 1985;25:474.
  24. Walker RH, ed. Technical manual. 11th ed. Bethesda: American Association of Blood Banks, 1993:676–8.
DOI: https://doi.org/10.21307/immunohematology-2019-929 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 90 - 94
Published on: Nov 30, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 R.J. Davey, S.S Esty, J.F. Chin, D. Mallory, published by American National Red Cross
This work is licensed under the Creative Commons License.